These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 4069550)

  • 1. Antiemetic efficacy of moderately high-dose metoclopramide in patients receiving varying doses of cisplatin. Controlled comparison with a combination of methylprednisolone and metoclopramide.
    Ell C; König HJ; Brockmann P; Domschke S; Domschke W
    Oncology; 1985; 42(6):354-7. PubMed ID: 4069550
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Antiemetic combination of metoclopramide and methylprednisolone for cisplatin-induced vomiting].
    Saito H; Amano H; Yasuda Y; Tsunekawa H; Fujimoto K; Yoshii S; Shimokata K
    Gan To Kagaku Ryoho; 1985 Oct; 12(10):1980-2. PubMed ID: 4051514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improved control of cisplatin-induced emesis with a combination of high doses of methylprednisolone and metoclopramide: a single-blind randomized trial.
    Bécouarn Y; Nguyen BB; David M; Lakdja F; Brunet R; Chauvergne J
    Eur J Cancer Clin Oncol; 1986 Dec; 22(12):1421-4. PubMed ID: 3595666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiemetic activity of high doses of metoclopramide combined with methylprednisolone versus metoclopramide alone in cisplatin-treated cancer patients: a randomized double-blind trial of the Italian Oncology Group for Clinical Research.
    Roila F; Tonato M; Basurto C; Bella M; Passalacqua R; Morsia D; DiCostanzo F; Donati D; Ballatori E; Tognoni G
    J Clin Oncol; 1987 Jan; 5(1):141-9. PubMed ID: 3543234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the antiemetic effect of high-dose intravenous metoclopramide and high-dose intravenous haloperidol in a randomized double-blind crossover study.
    Grunberg SM; Gala KV; Lampenfeld M; Jamin D; Johnson K; Cariffe P; Strych D; Krailo M
    J Clin Oncol; 1984 Jul; 2(7):782-7. PubMed ID: 6539812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A prospective randomized double-blind crossover study comparing the antiemetic activity of alizapride and metoclopramide in patients receiving cisplatin chemotherapy.
    Basurto C; Roila F; Del Favero A; Ballatori E; Minotti V; Tonato M
    Cancer Invest; 1988; 6(5):475-9. PubMed ID: 3063335
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Antiemetic efficacy of high-dose metoclopramide, diphenhydramine, methylprednisolone and diazepam on chemotherapy-induced emesis in gynecological malignancy].
    Hayashi Y; Iwasaka T; Hachisuga T; Fukuda K; Tanaka T; Matsuo N; Sugimori H
    Nihon Sanka Fujinka Gakkai Zasshi; 1988 Jul; 40(7):875-9. PubMed ID: 3418195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiemetic activity of high-dose metoclopramide combined with methylprednisolone versus metoclopramide alone in dacarbazine-treated cancer patients. A randomized double-blind study of the Italian Oncology Group for Clinical Research.
    Basurto C; Roila F; Tonato M; Ballatori E; Buzzi F; Calabresi F; Del Favero A
    Am J Clin Oncol; 1989 Jun; 12(3):235-8. PubMed ID: 2729180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiemetic regimens in outpatients receiving cisplatin and non-cisplatin chemotherapy. A randomized trial comparing high-dose metoclopramide plus methylprednisolone with and without lorazepam.
    González Barón M; Chacón JI; García Girón C; Ordóñez Gallego A; García de Paredes ML; Feliu J; Zamora P; Herranz C; Garrido P; Artal A
    Acta Oncol; 1991; 30(5):623-7. PubMed ID: 1892680
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Randomized crossover trial of the antiemetic effects obtained with metoclopramide and droperidol versus those obtained with metoclopramide, droperidol and methylprednisolone in patients receiving cis-platinum chemotherapy].
    Fujii M; Kiura K; Tamai M; Okabe K; Toki H
    Gan To Kagaku Ryoho; 1986 Aug; 13(8):2562-7. PubMed ID: 3527070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiemetic activity of oral lorazepam in addition to methylprednisolone and metoclopramide in the prophylactic treatment of vomiting induced by cisplatin. A double-blind, placebo-controlled study with crossover design.
    Clerico M; Bertetto O; Morandini MP; Cardinali C; Giaccone G
    Tumori; 1993 Apr; 79(2):119-22. PubMed ID: 8346563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of ondansetron with metoclopramide in prevention of acute emesis associated with low dose & high dose cisplatin chemotherapy.
    Bhatia A; Tripathi KD; Sharma M
    Indian J Med Res; 2003 Jul; 118():33-41. PubMed ID: 14748464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protection from nausea and vomiting in cisplatin-treated patients: high-dose metoclopramide combined with methylprednisolone versus metoclopramide combined with dexamethasone and diphenhydramine: a study of the Italian Oncology Group for Clinical Research.
    Roila F; Tonato M; Basurto C; Picciafuoco M; Bracarda S; Donati D; Malacarne P; Monici L; Di Costanzo F; Patoia L
    J Clin Oncol; 1989 Nov; 7(11):1693-700. PubMed ID: 2681556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Metoclopramide, methylprednisolone and flunitrazepam in cytostatic-induced vomiting].
    Joss R; Rohrbach D; Pirovino M; Bischoff A; Kiser J; Brunner K
    Schweiz Med Wochenschr; 1987 Dec; 117(52):2113-7. PubMed ID: 3433092
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Antiemetic efficacy of betamethasone versus betamethasone combined with metoclopramide in cisplatin-treated cancer patients].
    Kagami Y; Nishio M; Narimatsu N; Tomita M; Sakurai T
    Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 1):807-10. PubMed ID: 2712578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiemetic efficacy of high-dose intravenous metoclopramide and dexamethasone in patients receiving cisplatin-based chemotherapy: a randomized controlled trial.
    Shinkai T; Saijo N; Eguchi K; Sasaki Y; Tamura T; Tominaga K; Sakurai M; Sano T; Taito H; Takahashi H
    Jpn J Clin Oncol; 1986 Sep; 16(3):279-87. PubMed ID: 3534348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ondansetron + dexamethasone vs metoclopramide + dexamethasone + diphenhydramine in prevention of cisplatin-induced emesis. Italian Group For Antiemetic Research.
    Lancet; 1992 Jul; 340(8811):96-9. PubMed ID: 1352024
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiemetic efficacy of alprazolam in the combination of metoclopramide plus methylprednisolone. Double-blind randomized crossover study in patients with cisplatin-induced emesis.
    Mori K; Saito Y; Tominaga K
    Am J Clin Oncol; 1993 Aug; 16(4):338-41. PubMed ID: 8392288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparative study on the tolerance and efficacy of high doses of metoclopramide and clebopride in vomiting induced by cisplatin].
    Martín M; Díaz-Rubio E
    Med Clin (Barc); 1989 Jun; 93(2):50-3. PubMed ID: 2755259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy & tolerability of ondansetron compared to metoclopramide in dose dependent cisplatin-induced delayed emesis.
    Bhatia A; Tripathi KD; Sharma M
    Indian J Med Res; 2004 Sep; 120(3):183-93. PubMed ID: 15489556
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.